基本信息
views: 7
Career Trajectory
Bio
I Chair the Alberta Pre-Phase 1 Cancer Program that brings Alberta-made anticancer compounds to first-in-human testing, and work with academic collaborators to bring their ideas to the clinic. My translational research program focuses on developing tests to predict which patients are most likely to benefit from anticancer therapy, and exploiting novel targets and pathways to improve systemic cancer therapy.
My research program is funded by the Alberta Cancer Foundation, the Canadian Breast Cancer Research Alliance, the US Department of Defense, and multiple industry sponsors.
Research Interests
Papers共 543 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERINGno. 6 (2024): 1901-1912
Journal of Clinical Oncologyno. 16_suppl (2024)
Journal of sport and health scienceno. 6 (2024): 851-862
BioMedInformaticsno. 3 (2024): 1703-1712
Cancer Researchno. 7_Supplement (2024)
Investigational new drugsno. 4 (2024): 1-8
JACC: CardioOncologyno. 5 (2023): 686-700
crossref(2023)
Blood (2023): 6241
crossref(2023)
Load More
Author Statistics
#Papers: 550
#Citation: 42421
H-Index: 100
G-Index: 198
Sociability: 8
Diversity: 4
Activity: 87
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn